 |
Projets(s) de recherche, responsable |
| |
 |
Biochemical and structural studies of poly-TPR containing proteins involved in epigenetic signalling, Amélie Fradet-Turcotte
|
| |
|
Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays, Jean-Yves Masson
|
| |
|
Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays., Jacques Simard
|
| |
|
Correction by Prime editing of point mutations responsible for Cystic fibrosis in Quebec province, Jacques-P. Tremblay
|
| |
|
Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy
|
| |
|
Developing synthetic S100A9-based molecules for differentiation therapy of human acute myeloid leukemia, Philippe Tessier
|
| |
|
Early prediction and clinical impact of venous thrombo-embolism in children with cancer, Marie-Claude Pelland-Marcotte
|
| |
|
Emerging roles of Zinc Finger PAR-Interacting Proteins (ZIPPs) in DNA double-strand break (DSB) repair: implications in PARPi therapy, Guy Poirier
|
| |
|
MI SENS-OR REHAB: Feasibility, acceptability, and preliminary effects of a novel, multimodal, Motivational Interviewing-guided Somatosensory, Lynn Rollande Gauthier
|
| |
|
MI SENS-OR REHAB: Feasibility, acceptability, and preliminary effects of a novel, multimodal, Motivational Interviewing-guided somatoSENSory - motOR REHABilitation intervention for chemotherapy-induced peripheral neuropathy, Lynn Rollande Gauthier
|
| |
|
Omega-3 fatty acids in the prevention of breast cancer: role of obesity-related markers in breast tissues, Caroline Diorio
|
| |
|
Repurposing 5-alpha reductase inhibitors to improve outcomes for bladder cancer patients, Paul Toren
|
| |
|
Role and regulation of EPB41L5 in cancer-promoting cellular processes, Patrick Laprise
|
| |
|
Role of MYST-ING acetyltransferase complexes in transcription regulation, cell fate and disease, Jacques Côté
|
| |
|
Role of the RAS Pathway Activation on the Biology and Drug Response of Acute Myeloid Leukemias, Frédéric Barabé
|
| |
|
Targeting Early-Stage a -Synuclein Aggregation for Parkinson's Diseases Therapeutics, Abid Oueslati
|
| |
|
Targeting sex steroids to improve the response to bladder cancer immunotherapy, Paul Toren
|
| |
|
TBC1D9: therapeutic target of the aggressiveness of triple negative breast cancer
|
| |
|
The BUBR1 pseudokinase in Spindle Checkpoint Activation and Inactivation, Sabine Elowe
|
| |
|
The Ribosomal RNA Genes in the Control of Growth, Pluripotency, Senescence and Cancer, Thomas Moss
|
| |
|
Understanding Head and Neck Squamous Cell Carcinoma onset in young adults
|
| |
|
Understanding mitochondrial metabolism to identify prostate cancer metabolic vulnerabilities, Étienne Audet-Walsh
|
| |
|
Understanding the role of beta1 integrins in chemoresistance of acute lymphoblastic leukemia and therapeutic implications
|
| |
|
Unraveling the molecular mechanisms that promote replication stress and resistance to chemoradiation in oropharyngeal cancer caused by human papillomavirus, Amélie Fradet-Turcotte
|
| |
|
Unravelling the role of primary cilia in prostate cancer initiation and progression, Clémence Belleannée
|